Oorsprong van het eerstegraads netwerk van Regis Roche

EntiteitType entiteitIndustrie
4
Subsidiary Biotechnology 4
Public Company Medical Specialties 4

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Regis Roche via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
ATON Pharmaceuticals: Major

Jean-Paul Ansel

Julien Gauthier

Léone Atayi

Chairman

Chief Executive Officer

Chief Executive Officer

Real Estate Development

Jean-Paul Ansel

Samuel Sancerni

Corporate Officer/Principal

Corporate Officer/Principal

DMS IMAGING Biotechnology

Jean-Paul Ansel

Samuel Sancerni

Chairman

Director/Board Member

Apelem SASU

Jean-Paul Ansel

Samuel Sancerni

Chairman

Chief Executive Officer

Biotechnology

Jean-Paul Ansel

Léone Atayi

Director/Board Member

Chief Operating Officer

Electronic Equipment/Instruments

Jean-Paul Ansel

Chairman

AUPLATA MINING GROUP - AMG Precious Metals

Mathieu Omnes

Investor Relations Contact

GOLD BY GOLD Other Metals/Minerals

Mathieu Omnes

Investor Relations Contact

Adip’Sculpt SAS

Jean-Paul Ansel

Chairman

INDEX MULTIMEDIA Internet Software/Services

Jean-Paul Ansel

President

Merix SARL

Jean-Paul Ansel

Corporate Officer/Principal

Apelem Espana SA

Jean-Paul Ansel

Chairman

Oilfield Services/Equipment

Jean-Paul Ansel

Chief Executive Officer

ALPHA MOS Electronic Equipment/Instruments

Jean-Paul Ansel

Chief Executive Officer

Engineering & Construction

Jean-Paul Ansel

President

Medilink SARL

Jean-Paul Ansel

Corporate Officer/Principal

Electronic Equipment/Instruments

Samuel Sancerni

Chairman

Statistieken

Internationaal

Frankrijk 16
België 2
Spanje 2
Zuid-Korea 2

Sectoraal

Health Technology 4
Electronic Technology 4
Finance 3
Non-Energy Minerals 3
Industrial Services 3

Operationeel

Chairman 11
Chief Executive Officer 8
Corporate Officer/Principal 7
Director/Board Member 7
Investor Relations Contact 6
  1. Beurs
  2. Insiders
  3. Regis Roche
  4. Bedrijfsconnecties
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU